Literature DB >> 35405280

Nuclear targeting Subcellular-delivery nanosystems for precise cancer treatment.

Wenzhen Du1, Lijing Zhang1, Xiaodan Li1, Guixia Ling2, Peng Zhang3.   

Abstract

With the exponential growth of nanomedicine research, subcellular-delivery nanosystems (SDNSs) has rapidly become a research focus, which suggests that the idea of curing cancer may not be a pipe dream. As the center of genetic material storage, replication, and transcription, the nucleus can be regarded as the final target of many cancer treatment methods. Thus, nuclear-targeted SDNSs may have clinical potential for precise cancer treatment by delivering therapeutic agents and assisting various treatment methods. Herein, the latest progress of nuclear-targeted SDNSs for cancer treatment are reviewed and listed. Additionally, the possible mechanisms of SDNSs entering the nucleus and its applications in the field of cancer treatment as well as some typical preparations are summarized and the exciting future of SDNSs is also briefly highlighted.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer; Mechanisms; Nano-delivery system; Nuclear target

Mesh:

Substances:

Year:  2022        PMID: 35405280     DOI: 10.1016/j.ijpharm.2022.121735

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  2 in total

1.  Computational AI Models for Investigating the Radiation Shielding Potential of High-Density Concrete.

Authors:  Muhammad Nasir Amin; Izaz Ahmad; Mudassir Iqbal; Asim Abbas; Kaffayatullah Khan; Muhammad Iftikhar Faraz; Anas Abdulalim Alabdullah; Shahid Ullah
Journal:  Materials (Basel)       Date:  2022-06-29       Impact factor: 3.748

2.  Estimating Radiation Shielding of Fired Clay Bricks Using ANN and GEP Approaches.

Authors:  Muhammad Nasir Amin; Izaz Ahmad; Asim Abbas; Kaffayatullah Khan; Muhammad Ghulam Qadir; Mudassir Iqbal; Abdullah Mohammad Abu-Arab; Anas Abdulalim Alabdullah
Journal:  Materials (Basel)       Date:  2022-08-26       Impact factor: 3.748

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.